Ingre, France

Hugues M H Martin

This inventor holds 2 USPTO granted patents. Top assignee: 3M Innovative Properties Company. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hugues M H Martin. Retrieved from https://idiyas.com/inventor/hugues-m-h-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.9

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hugues M H Martin: Innovator in Immunomodulatory Compounds

Introduction

Hugues M H Martin is a notable inventor based in Ingre, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of immunomodulatory compounds. With a total of 2 patents, his work has implications for treating various diseases.

Latest Patents

Martin's latest patents focus on Aryloxy and arylalkyleneoxy substituted imidazoquinolines. These imidazoquinoline compounds feature an aryloxy or arylalkyleneoxy substituent at the 6, 7, 8, or 9-position. The patents disclose pharmaceutical compositions containing these compounds, intermediates, and methods of use as immunomodulators. They are designed for modulating cytokine biosynthesis in animals and for treating diseases, including viral and neoplastic diseases.

Career Highlights

Hugues M H Martin is associated with 3M Innovative Properties Company, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical treatments through scientific research and development.

Collaborations

Martin has collaborated with notable coworkers, including Kyle J Lindstrom and Bryon A Merrill. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Hugues M H Martin stands out as an influential inventor in the realm of immunomodulatory compounds. His contributions are paving the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…